rs61736603

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004211.5(SLC6A5):​c.500C>A​(p.Thr167Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00325 in 1,614,056 control chromosomes in the GnomAD database, including 187 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. T167T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.017 ( 93 hom., cov: 33)
Exomes 𝑓: 0.0018 ( 94 hom. )

Consequence

SLC6A5
NM_004211.5 missense

Scores

6
12

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 5.63

Publications

4 publications found
Variant links:
Genes affected
SLC6A5 (HGNC:11051): (solute carrier family 6 member 5) This gene encodes a sodium- and chloride-dependent glycine neurotransmitter transporter. This integral membrane glycoprotein is responsible for the clearance of extracellular glycine during glycine-mediated neurotransmission. This protein is found in glycinergic axons and maintains a high presynaptic pool of neurotransmitter at glycinergic synapses. Mutations in this gene cause hyperekplexia; a heterogenous neurological disorder characterized by exaggerated startle responses and neonatal apnea. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2016]
SLC6A5 Gene-Disease associations (from GenCC):
  • hyperekplexia 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • hereditary hyperekplexia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003014952).
BP6
Variant 11-20601625-C-A is Benign according to our data. Variant chr11-20601625-C-A is described in ClinVar as Benign. ClinVar VariationId is 304012.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0575 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC6A5NM_004211.5 linkc.500C>A p.Thr167Lys missense_variant Exon 2 of 16 ENST00000525748.6 NP_004202.4 Q9Y345-1Q4VAM4Q4VAM6
SLC6A5NM_001318369.2 linkc.-64C>A 5_prime_UTR_variant Exon 2 of 15 NP_001305298.1 Q9Y345-2Q4VAM4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC6A5ENST00000525748.6 linkc.500C>A p.Thr167Lys missense_variant Exon 2 of 16 1 NM_004211.5 ENSP00000434364.2 Q9Y345-1
SLC6A5ENST00000298923.11 linkn.500C>A non_coding_transcript_exon_variant Exon 2 of 15 1 ENSP00000298923.7 J3KNC4

Frequencies

GnomAD3 genomes
AF:
0.0170
AC:
2594
AN:
152206
Hom.:
94
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0595
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00576
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000162
Gnomad OTH
AF:
0.0129
GnomAD2 exomes
AF:
0.00463
AC:
1153
AN:
248834
AF XY:
0.00358
show subpopulations
Gnomad AFR exome
AF:
0.0636
Gnomad AMR exome
AF:
0.00261
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000188
Gnomad OTH exome
AF:
0.00115
GnomAD4 exome
AF:
0.00180
AC:
2638
AN:
1461732
Hom.:
94
Cov.:
35
AF XY:
0.00158
AC XY:
1149
AN XY:
727172
show subpopulations
African (AFR)
AF:
0.0646
AC:
2164
AN:
33474
American (AMR)
AF:
0.00277
AC:
124
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39692
South Asian (SAS)
AF:
0.000255
AC:
22
AN:
86248
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53366
Middle Eastern (MID)
AF:
0.00225
AC:
13
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000755
AC:
84
AN:
1111950
Other (OTH)
AF:
0.00383
AC:
231
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
151
302
453
604
755
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0171
AC:
2601
AN:
152324
Hom.:
93
Cov.:
33
AF XY:
0.0165
AC XY:
1232
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.0595
AC:
2473
AN:
41568
American (AMR)
AF:
0.00575
AC:
88
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000162
AC:
11
AN:
68026
Other (OTH)
AF:
0.0128
AC:
27
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
123
246
370
493
616
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00389
Hom.:
26
Bravo
AF:
0.0196
ESP6500AA
AF:
0.0626
AC:
276
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.00572
AC:
695
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.000178

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hyperekplexia 3 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hyperekplexia Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

SLC6A5-related disorder Benign:1
Jun 13, 2024
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.35
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.27
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.065
T
Eigen
Uncertain
0.23
Eigen_PC
Uncertain
0.37
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.86
D
MetaRNN
Benign
0.0030
T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
1.6
L
PhyloP100
5.6
PrimateAI
Benign
0.47
T
PROVEAN
Benign
-0.56
N
REVEL
Benign
0.29
Sift
Benign
0.16
T
Sift4G
Benign
0.13
T
Polyphen
0.55
P
Vest4
0.43
MVP
0.87
MPC
0.29
ClinPred
0.045
T
GERP RS
5.4
Varity_R
0.22
gMVP
0.57
Mutation Taster
=69/31
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61736603; hg19: chr11-20623171; COSMIC: COSV54229016; API